Actavis (ACT) Price Target Raised to $280 at Goldman Sachs
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- S&P 500, Nasdaq futures tick up as tech steadies, Micron earnings eyed
- Brent extends losses on expectations of smoother crude flows via Hormuz
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Needham Starts NeoVolta (NEOV) at Buy
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Filing Shows Allergan (AGN), Actavis (ACT) Talks Continue
November 6, 2014 9:23 AM ESTAn SEC filing by Allergan (NYSE: AGN) shows takeover talks with a third party believed to be Actavis Plc (NYSE: ACT) have continued. The text from the filing is below.
"Notwithstanding the foregoing, we have been approached by... More
Valeant Pharma (VRX) on Watch on Actavis/Allergan Headlines
November 6, 2014 9:21 AM ESTValeant Pharma (NYSE: VRX) on watch as Actavis Plc (NYSE: ACT) is said to be in advanced takeover talks with Allergan (NYSE: AGN), according to Bloomberg. Valeant is pursing its own hostile bid for AGN.
... MoreActavis Plc (ACT) said to be in active takeover talks with Allergan (AGN) - Bloomberg
November 6, 2014 9:19 AM ESTActavis Plc (NYSE: ACT) said to be in active takeover talks with Allergan (NYSE: AGN) according to Bloomberg.
... MoreActavis Plc (ACT) Tops Q3 EPS by 9c
November 5, 2014 6:31 AM ESTActavis Plc (NYSE: ACT) reported Q3 EPS of $3.19, $0.09 better than the analyst estimate of $3.10. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $3.63 billion.
Raises H214 adjusted EPS outlook to $6.60 - $6.70.
For earnings history and earnings-related data on Actavis Plc (ACT) click here.
... More